Loading clinical trials...
Loading clinical trials...
Non-invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-derived Cell-free DNA in Peripheral Blood
Conditions
Interventions
dd-cfDNA Blood Test
Locations
3
United States
Georgetown University
Washington D.C., District of Columbia, United States
University of Maryland
Baltimore, Maryland, United States
UW Health University Hospital
Madison, Wisconsin, United States
Start Date
September 1, 2019
Primary Completion Date
July 30, 2024
Completion Date
September 6, 2024
Last Updated
November 27, 2024
NCT05613010
NCT03778944
NCT06089473
NCT03436368
NCT03380962
NCT06496269
Lead Sponsor
University of Maryland, Baltimore
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions